Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
2.315
-0.655 (-22.05%)
Jul 11, 2025, 12:03 PM - Market open

Basel Medical Group Cash Flow Statement

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22
Net Income
0.432.071.781.98
Depreciation & Amortization
0.620.530.560.58
Asset Writedown & Restructuring Costs
--0.05-
Provision & Write-off of Bad Debts
-0.01-0.010.160.03
Other Operating Activities
-0.5-0.08-0.230.13
Change in Accounts Receivable
-1.86-0.420.540.01
Change in Inventory
0.010.02-0.020
Change in Accounts Payable
-0.110.39-0.220.06
Operating Cash Flow
-1.422.512.62.79
Operating Cash Flow Growth
--3.49%-6.89%-
Capital Expenditures
-0.02-0.01-0.01-0.09
Investing Cash Flow
0.04-0.01-0.01-0.09
Short-Term Debt Issued
-1.42--
Long-Term Debt Issued
---1.03
Total Debt Issued
5.391.42-1.03
Short-Term Debt Repaid
----10.86
Long-Term Debt Repaid
--2.92-2.94-3.09
Total Debt Repaid
-6.78-2.92-2.94-13.95
Net Debt Issued (Repaid)
-1.39-1.5-2.94-12.92
Other Financing Activities
9.3-0.270-
Financing Cash Flow
7.9-1.77-2.94-12.92
Net Cash Flow
6.50.73-0.35-10.22
Free Cash Flow
-1.442.52.592.7
Free Cash Flow Growth
--3.56%-4.07%-
Free Cash Flow Margin
-14.40%24.84%26.61%25.37%
Free Cash Flow Per Share
-0.090.150.160.17
Cash Interest Paid
0.180.180.240.32
Cash Income Tax Paid
0.330.410.290.03
Levered Free Cash Flow
11.221.431.89-
Unlevered Free Cash Flow
11.41.542.04-
Change in Net Working Capital
-10.990.32-0.24-
Updated Nov 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q